Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial.

Abou-Alfa GK, Shi Q, Knox JJ, Kaubisch A, Niedzwiecki D, Posey J, Tan BR Jr, Kavan P, Goel R, Lammers PE, Bekaii-Saab TS, Tam VC, Rajdev L, Kelley RK, El Dika I, Zemla T, Potaracke RI, Balletti J, El-Khoueiry AB, Harding JH, Suga JM, Schwartz LH, Goldberg RM, Bertagnolli MM, Meyerhardt J, O'Reilly EM, Venook AP.

JAMA Oncol. 2019 Sep 5. doi: 10.1001/jamaoncol.2019.2792. [Epub ahead of print] Erratum in: JAMA Oncol. 2019 Oct 10;:.

PMID:
31486832
2.

Bispecific Antibodies in the Treatment of Hematologic Malignancies.

Duell J, Lammers PE, Djuretic I, Chunyk AG, Alekar S, Jacobs I, Gill S.

Clin Pharmacol Ther. 2019 Oct;106(4):781-791. doi: 10.1002/cpt.1396. Epub 2019 Mar 29. Review.

3.

Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancer.

Lammers PE, Dank M, Masetti R, Abbas R, Hilton F, Coppola J, Jacobs I.

Br J Cancer. 2018 Aug;119(3):266-273. doi: 10.1038/s41416-018-0147-1. Epub 2018 Jul 13.

4.

High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx.

Babaer D, Amara S, Ivy M, Zhao Y, Lammers PE, Titze JM, Tiriveedhi V.

Oncotarget. 2018 May 18;9(38):25193-25205. doi: 10.18632/oncotarget.25391. eCollection 2018 May 18.

5.

A rapidly growing human papillomavirus-positive oral tongue squamous cell carcinoma in a 21-year old female: A case report.

Appah EO, Ballard BR, Izban MG, Jolin C, Lammers PE, Parrish DD Jr, Marshall DR.

Oncol Lett. 2018 May;15(5):7702-7706. doi: 10.3892/ol.2018.8339. Epub 2018 Mar 23.

6.

Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey.

Monk BJ, Lammers PE, Cartwright T, Jacobs I.

Pharmaceuticals (Basel). 2017 Jan 28;10(1). pii: E19. doi: 10.3390/ph10010019.

7.

Fetuin-A (alpha 2HS glycoprotein) modulates growth, motility, invasion, and senescence in high-grade astrocytomas.

Nangami GN, Sakwe AM, Izban MG, Rana T, Lammers PE, Thomas P, Chen Z, Ochieng J.

Cancer Med. 2016 Dec;5(12):3532-3543. doi: 10.1002/cam4.940. Epub 2016 Nov 23.

8.

Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis.

Boutaud O, Sosa IR, Amin T, Oram D, Adler D, Hwang HS, Crews BC, Milne G, Harris BK, Hoeksema M, Knollmann BC, Lammers PE, Marnett LJ, Massion PP, Oates JA.

Cancer Prev Res (Phila). 2016 Nov;9(11):855-865. Epub 2016 Aug 23.

9.

Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma.

Coleman M, Lammers PE, Ciceri F, Jacobs IA.

Clin Lymphoma Myeloma Leuk. 2016 Apr;16(4):175-81. doi: 10.1016/j.clml.2016.01.004. Epub 2016 Jan 30. Review.

PMID:
26906106
10.

Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled Analysis.

Araujo LH, Lammers PE, Matthews-Smith V, Eisenberg R, Gonzalez A, Schwartz AG, Timmers C, Shilo K, Zhao W, Natarajan TG, Zhang J, Yilmaz AS, Liu T, Coombes K, Carbone DP.

J Thorac Oncol. 2015 Oct;10(10):1430-6. doi: 10.1097/JTO.0000000000000650.

11.

Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing.

Araujo LH, Timmers C, Bell EH, Shilo K, Lammers PE, Zhao W, Natarajan TG, Miller CJ, Zhang J, Yilmaz AS, Liu T, Coombes K, Amann J, Carbone DP.

J Clin Oncol. 2015 Jun 10;33(17):1966-73. doi: 10.1200/JCO.2014.59.2444. Epub 2015 Apr 27.

12.

Phase II study of bendamustine in relapsed chemotherapy sensitive or resistant small-cell lung cancer.

Lammers PE, Shyr Y, Li CI, Hutchison AS, Sandler A, Carbone DP, Johnson DH, Keedy VL, Horn L.

J Thorac Oncol. 2014 Apr;9(4):559-62. doi: 10.1097/JTO.0000000000000079.

14.

A randomized phase II trial investigating the effect of platelet function inhibition on circulating tumor cells in patients with metastatic breast cancer.

Roop RP, Naughton MJ, Van Poznak C, Schneider JG, Lammers PE, Pluard TJ, Johnson F, Eby CS, Weilbaecher KN.

Clin Breast Cancer. 2013 Dec;13(6):409-15. doi: 10.1016/j.clbc.2013.08.006.

15.

Targeting angiogenesis in advanced non-small cell lung cancer.

Lammers PE, Horn L.

J Natl Compr Canc Netw. 2013 Oct 1;11(10):1235-47. Review.

16.

Membrane insertion of betaine/GABA transporter during hypertonic stress correlates with nuclear accumulation of TonEBP.

Kempson SA, Beck JA, Lammers PE, Gens JS, Montrose MH.

Biochim Biophys Acta. 2005 Jun 15;1712(1):71-80. Epub 2005 Apr 7.

17.

Hypertonic upregulation of betaine transport in renal cells is blocked by a proteasome inhibitor.

Lammers PE, Beck JA, Chu S, Kempson SA.

Cell Biochem Funct. 2005 Sep-Oct;23(5):315-24.

PMID:
15945068

Supplemental Content

Loading ...
Support Center